Kinney Horn
Corporate Officer/Principal bij IMMUNOME, INC.
Vermogen: 27 825 $ op 31-03-2024
Profiel
Mr. Kinney Horn is a Chief Business Officer at Immunome, Inc. Mr. Horn was previously employed as a Chief Business Officer by Olema Pharmaceuticals, Inc. and a Director-Business Development by Genentech, Inc. He received his undergraduate degree from the University of Mary Washington and a graduate degree from Georgetown University.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 01-02-2023 | 2 458 ( 0.00% ) | 27 825 $ | 31-03-2024 |
Actieve functies van Kinney Horn
| Bedrijven | Functie | Begin |
|---|---|---|
| IMMUNOME, INC. | Corporate Officer/Principal | 01-02-2024 |
Eerdere bekende functies van Kinney Horn
| Bedrijven | Functie | Einde |
|---|---|---|
| OLEMA PHARMACEUTICALS, INC. | Corporate Officer/Principal | 24-03-2023 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 01-04-2019 |
Opleiding van Kinney Horn
| Georgetown University | Graduate Degree |
| University of Mary Washington | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| IMMUNOME, INC. | Health Technology |
| OLEMA PHARMACEUTICALS, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
